At the same time, CCL3 (Koca et al., 2022), CCL15 (Marksteiner et al., 2011), CCL18 (Marksteiner et al., 2011), and IL-13 (Mohd Hasni et al., 2017) decreased in AD patients compared to controls. This evidence concerns the gene IL13 and Alzheimer disease.